JAMA cardiology Journal

•  
• Overview
•  
• Identity
•  
• View All
•  

Overview

publication venue for

• Verinurad Plus Allopurinol for Heart Failure With Preserved Ejection Fraction: The AMETHYST Randomized Clinical Trial..  9:892-900. 2024
• Cardiac Myosin Inhibition in Heart Failure With Normal and Supranormal Ejection Fraction: Primary Results of the EMBARK-HFpEF Trial. 2024
• High Throughput Plasma Proteomics and Risk of Heart Failure and Frailty in Late Life..  9:649-658. 2024
• Osteosarcopenia and Mortality in Older Adults Undergoing Transcatheter Aortic Valve Replacement..  9:611-618. 2024
• A Multimodal Video-Based AI Biomarker for Aortic Stenosis Development and Progression..  9:534-544. 2024
• Genetic Associations of Circulating Cardiovascular Proteins With Gestational Hypertension and Preeclampsia..  9:209-220. 2024
• Precision Measurement of Telomere Length as a Future Guide to Improve CVD Interventions..  9:-. 2024
• Private Equity and Cardiovascular Health Care..  9:203-204. 2024
• Risk Prediction for Atherosclerotic Cardiovascular Disease With and Without Race Stratification..  9:55-62. 2024
• Mitochondrial Respiration and Exercise Performance in Patients With Heart Failure With Preserved Ejection Fraction-Reply..  8:1101-1102. 2023
• Comparison of an Initial Risk-Based Testing Strategy vs Usual Testing in Stable Symptomatic Patients With Suspected Coronary Artery Disease: The PRECISE Randomized Clinical Trial..  8:904-914. 2023
• Deferred Testing in Stable Outpatients With Suspected Coronary Artery Disease: A Prespecified Secondary Analysis of the PRECISE Randomized Clinical Trial..  8:915-924. 2023
• Defining a Precise Diagnostic Strategy for Suspected Coronary Artery Disease-Lessons Learned From the PRECISE Trial..  8:902-903. 2023
• Frailty-Guided Management of Cardiovascular Disease-From Clinical Trials to Clinical Practice..  8:897-898. 2023
• Skeletal Muscle Mitochondrial Respiration and Exercise Intolerance in Patients With Heart Failure With Preserved Ejection Fraction..  8:575-584. 2023
• Frailty and Effects of a Multidomain Physical Rehabilitation Intervention Among Older Patients Hospitalized for Acute Heart Failure: A Secondary Analysis of a Randomized Clinical Trial..  8:167-176. 2023
• Use of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagonlike Peptide-1 Receptor Agonists in Patients With Diabetes and Cardiovascular Disease in Community Practice..  8:89-95. 2023
• Association of Race and Ethnicity With Oral Anticoagulation and Associated Outcomes in Patients With Atrial Fibrillation: Findings From the Get With The Guidelines-Atrial Fibrillation Registry..  7:1207-1217. 2022
• Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control: A Secondary Analysis of a Randomized Clinical Trial..  7:1138-1146. 2022
• Association of Transcatheter Aortic Valve Replacement Reimbursement, New Technology Add-on Payment, and Procedure Volumes With Embolic Protection Device Use..  7:945-952. 2022
• Improving Enrollment of Underrepresented Racial and Ethnic Populations in Heart Failure Trials: A Call to Action From the Heart Failure Collaboratory..  7:540-548. 2022
• Association of Premature Ventricular Contraction Burden on Serial Holter Monitoring With Arrhythmic Risk in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy..  7:378-385. 2022
• Economic Outcomes of Rehabilitation Therapy in Older Patients With Acute Heart Failure in the REHAB-HF Trial: A Secondary Analysis of a Randomized Clinical Trial..  7:140-148. 2022
• National Trends in Heart Failure Hospitalization and Readmissions Associated With Policy Changes..  7:-. 2022
• Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels With Outcomes After Intensive Blood Pressure Lowering: Findings From the SPRINT Randomized Clinical Trial..  6:1397-1405. 2021
• Performance of the American Heart Association/American College of Cardiology Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Self-reported Physical Activity Levels..  6:690-696. 2021
• Association of Left Ventricular Systolic Function With Incident Heart Failure in Late Life..  6:509-520. 2021
• Association of Genetic West African Ancestry, Blood Pressure Response to Therapy, and Cardiovascular Risk Among Self-Reported Black Individuals in the Systolic Blood Pressure Reduction Intervention Trial (SPRINT)..  6:388-398. 2021
• Effect of a Self-care Intervention on 90-Day Outcomes in Patients With Acute Heart Failure Discharged From the Emergency Department: A Randomized Clinical Trial..  6:200-208. 2021
• Evaluation of Risk-Adjusted Home Time After Hospitalization for Heart Failure as a Potential Hospital Performance Metric..  6:169-176. 2021
• Association of Visit-to-Visit Variability in Kidney Function and Serum Electrolyte Indexes With Risk of Adverse Clinical Outcomes Among Patients With Heart Failure With Preserved Ejection Fraction..  6:68-77. 2021
• Frequency and Outcomes of Preoperative Stress Testing in Total Hip and Knee Arthroplasty from 2004 to 2017..  6:13-20. 2021
• Trends in Utilization and Cost of Low-Density Lipoprotein Cholesterol-Lowering Therapies Among Medicare Beneficiaries: An Analysis From the Medicare Part D Database..  6:92-96. 2021
• Frailty Measurement Using Administrative Data in Older Patients With Cardiovascular Disease..  5:967-968. 2020
• Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial..  5:598-607. 2020
• Contemporary Patterns of Medicare and Medicaid Utilization and Associated Spending on Sacubitril/Valsartan and Ivabradine in Heart Failure..  5:336-339. 2020
• Age-Related Differences in the Noninvasive Evaluation for Possible Coronary Artery Disease: Insights From the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) Trial..  5:193-201. 2020
• Temporal Trends in Racial Differences in 30-Day Readmission and Mortality Rates After Acute Myocardial Infarction Among Medicare Beneficiaries..  5:136-145. 2020
• Translating the Secondary Prevention Therapeutic Boom Into Action..  5:215-216. 2020
• Association of Lipidomic Profiles With Progression of Carotid Artery Atherosclerosis in HIV Infection..  4:1239-1249. 2019
• Interpreting the Prognostic Value of Unrecognized Myocardial Infarction Among Older Adults..  4:-. 2019
• Evaluating Treatment Effect of Transcatheter Interatrial Shunt Device Using Heart Failure Event Rates..  4:-. 2019
• Assessment of the Relationship Between Genetic Determinants of Thyroid Function and Atrial Fibrillation: A Mendelian Randomization Study..  4:144-152. 2019
• Cardiovascular Risk Factors Associated With Venous Thromboembolism..  4:163-173. 2019
• Association of Cardiac Injury and Malignant Left Ventricular Hypertrophy With Risk of Heart Failure in African Americans: The Jackson Heart Study..  4:51-58. 2019
• Right Ventricular Function, Right Ventricular-Pulmonary Artery Coupling, and Heart Failure Risk in 4 US Communities: The Atherosclerosis Risk in Communities (ARIC) Study..  3:939-948. 2018
• Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use: Insights From the Patient and Provider Assessment of Lipid Management Registry..  3:739-748. 2018
• Association of Hospital Performance Based on 30-Day Risk-Standardized Mortality Rate With Long-term Survival After Heart Failure Hospitalization: An Analysis of the Get With The Guidelines-Heart Failure Registry..  3:489-497. 2018
• Estimating Treatment Effect With Clinical Interpretation From a Comparative Clinical Trial With an End Point Subject to Competing Risks..  3:357-358. 2018
• Association of Cardiovascular Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction..  3:215-224. 2018
• Association of Depression With Mortality in Older Adults Undergoing Transcatheter or Surgical Aortic Valve Replacement..  3:191-197. 2018
• Evaluating Readmission-Need for More Clarity on Methods..  3:-. 2018
• Role of Hospital Volumes in Identifying Low-Performing and High-Performing Aortic and Mitral Valve Surgical Centers in the United States..  2:1322-1331. 2017
• Restricted Mean Survival Time as a Measure to Interpret Clinical Trial Results..  2:1179-1180. 2017
• Association of Changes in Medication Use and Adherence With Accountable Care Organization Exposure in Patients With Cardiovascular Disease or Diabetes..  2:1019-1023. 2017
• Association of Coronary Artery Calcium Score vs Age With Cardiovascular Risk in Older Adults: An Analysis of Pooled Population-Based Studies..  2:986-994. 2017
• Sildenafil Treatment in Heart Failure With Preserved Ejection Fraction: Targeted Metabolomic Profiling in the RELAX Trial..  2:896-901. 2017
• Association of US Centers for Medicare and Medicaid Services Hospital 30-Day Risk-Standardized Readmission Metric With Care Quality and Outcomes After Acute Myocardial Infarction: Findings From the National Cardiovascular Data Registry/Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines..  2:723-731. 2017
• Potential of Oncocardiology..  2:-. 2017
• Absolute Rates of Heart Failure, Coronary Heart Disease, and Stroke in Chronic Kidney Disease: An Analysis of 3 Community-Based Cohort Studies..  2:314-318. 2017
• Factors Associated With and Prognostic Implications of Cardiac Troponin Elevation in Decompensated Heart Failure With Preserved Ejection Fraction: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program..  2:136-145. 2017
• Can We Improve Mortality Estimation in Women After Treadmill Testing by Using Sex-Specific Scores?.  2:22-24. 2017
• Data Desert for Inferior Vena Caval Filters: Limited Evidence, Supervision, and Research..  2:3-4. 2017
• Use of Risk Models to Predict Death in the Next Year Among Individual Ambulatory Patients With Heart Failure..  2:435-441. 2017
• Effect of Drug Interactions and Adherence to Warfarin Therapy on Patients-Reply..  1:-. 2016
• Treatment, Outcomes, and Adherence to Medication Regimens Among Dual Medicare-Medicaid-Eligible Adults With Myocardial Infarction..  1:787-794. 2016
• Cardiovascular Events in a Physical Activity Intervention Compared With a Successful Aging Intervention: The LIFE Study Randomized Trial..  1:568-74. 2016
• Continuous Dose-Response Association Between Sedentary Time and Risk for Cardiovascular Disease: A Meta-analysis..  1:575-83. 2016
• Resuscitation Practices Associated With Survival After In-Hospital Cardiac Arrest: A Nationwide Survey..  1:189-97. 2016
• The US Food and Drug Administration 515 Program Initiative: Addressing the Evidence Gap for Widely Used, High-Risk Cardiovascular Devices?.  1:117-8. 2016
• Incidence and Determinants of Traumatic Intracranial Bleeding Among Older Veterans Receiving Warfarin for Atrial Fibrillation..  1:65-72. 2016
• Moving From Disease-Centered to Patient Goals-Directed Care for Patients With Multiple Chronic Conditions: Patient Value-Based Care..  1:9-10. 2016

Identity

International Standard Serial Number (ISSN)

• 2380-6591